COTI

CNX Resources (NYSE:CNX) Earns Underweight Rating from Analysts at Morgan Stanley

10 Jan 2025 09:46:15 By Buzz FX

HC Wainwright Issues Positive Forecast for Exelixis (NASDAQ:EXEL) Stock Price

10 Jan 2025 09:46:15 By Buzz FX

Haleon (NYSE:HLN) Rating Lowered to Equal Weight at Morgan Stanley

10 Jan 2025 09:46:15 By Buzz FX

Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price Expected to Rise, HC Wainwright Analyst Says

10 Jan 2025 09:46:15 By Buzz FX

Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from HC Wainwright

10 Jan 2025 09:11:14 By Buzz FX

Telsey Advisory Group Forecasts Strong Price Appreciation for Honest (NASDAQ:HNST) Stock

10 Jan 2025 09:11:14 By Buzz FX

Walgreens Boots Alliance (NASDAQ:WBA) Issues Earnings Results, Beats Expectations By $0.13 EPS

10 Jan 2025 09:11:14 By Buzz FX

3 Stocks Riding NVIDIA's AI Wave: MU, UBER, LOGI

10 Jan 2025 09:11:14 By Buzz FX

Avadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from HC Wainwright

10 Jan 2025 09:04:14 By Buzz FX

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright

10 Jan 2025 09:04:14 By Buzz FX

Piper Sandler Initiates Coverage on Monopar Therapeutics (NASDAQ:MNPR)

10 Jan 2025 09:04:14 By Buzz FX

Phathom Pharmaceuticals' (PHAT) Buy Rating Reaffirmed at Needham & Company LLC

10 Jan 2025 09:04:14 By Buzz FX

Maplebear (NASDAQ:CART) Coverage Initiated by Analysts at Wells Fargo & Company

10 Jan 2025 09:04:14 By Buzz FX

C.H. Robinson Worldwide (NASDAQ:CHRW) Rating Increased to Outperform at Raymond James

10 Jan 2025 09:03:15 By Buzz FX

Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright

10 Jan 2025 09:03:15 By Buzz FX

RCI Hospitality (NASDAQ:RICK) Receives Buy Rating from HC Wainwright

10 Jan 2025 09:03:15 By Buzz FX

BigCommerce (NASDAQ:BIGC) Stock Rating Lowered by Barclays

10 Jan 2025 09:03:15 By Buzz FX

Morgan Stanley Upgrades Gilead Sciences (NASDAQ:GILD) to "Overweight"

10 Jan 2025 09:03:15 By Buzz FX

Northland Securities Boosts Bitdeer Technologies Group (NASDAQ:BTDR) Price Target to $24.00

10 Jan 2025 09:03:15 By Buzz FX

Cytokinetics (NASDAQ:CYTK) Receives Buy Rating from HC Wainwright

10 Jan 2025 09:03:15 By Buzz FX